Hebei Medical University Fourth Hospital
Clinical trials sponsored by Hebei Medical University Fourth Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New trial tests which chemo combo best shrinks tough breast tumors Results expected Oct 2026 (estimated)
- New combo therapy aims to wipe out breast cancer before surgery Results expected Oct 2026 (estimated)
- One-Time radiation during breast surgery could cut treatment time Results expected Nov 2026 (estimated)
- New drug combo aims to fight advanced esophageal cancer Results expected Dec 2026 (estimated)
- New pill combo aims to wipe out breast tumors before surgery Results expected Dec 2026 (estimated)
-
Can a genetic marker make rectal cancer treatment more precise?
Disease control OngoingThis trial is testing whether a combination of chemotherapy drugs (liposomal irinotecan and capecitabine) plus radiation, given before surgery, can help people with locally advanced rectal cancer. The treatment plan is personalized based on a genetic marker (UGT1A1) that affects …
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a targeted radiation combo boost rectal cancer remission?
Disease control PausedThis trial is testing whether a more focused radiation field, combined with chemotherapy and an immunotherapy drug called camrelizumab, can improve outcomes for people with a certain type of locally advanced rectal cancer. The study will compare this new approach to a standard tr…
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New pill combo aims to wipe out breast tumors before surgery
Disease control OngoingThis study tests whether adding the targeted drug pyrotinib to standard chemotherapy and trastuzumab can completely eliminate HER2-positive breast tumors before surgery. About 113 women with early-stage HER2+ breast cancer will receive the combination, then have surgery to check …
Phase 2/3 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC